Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
about
Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence ImagingUshering in the study and treatment of preclinical Alzheimer diseaseRelations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative studyIn vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocinBasal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.Neuroimaging in Alzheimer's disease: relevance for treatment.Brain imaging in dementia of the Alzheimer type.7.0T nuclear magnetic resonance evaluation of the amyloid beta (1-40) animal model of Alzheimer's disease: comparison of cytology verification.Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects.Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performanceAssociation of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis.Mixed dementia: epidemiology, diagnosis, and treatment.Application of pet imaging to diagnosis of Alzheimer's disease and mild cognitive impairment.Cognition activators.Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease.Scopolamine reduces frontal cortex perfusion.Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte D-glucose transport.Biochemical measurements in Alzheimer's disease reveal a necessity for improved neuroimaging techniques to study metabolism.Cortical glucose metabolism in Parkinson's and Alzheimer's disease.Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Correlation of Histopathology and MRI in Prion Disease.Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT.Characterization of Cerebral Damage in a Monkey Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin.Effects of damage to the basal forebrain on brain glucose utilization: a reevaluation using positron emission tomography in baboons with extensive unilateral excitotoxic lesion.Positron emission tomography in degenerative disorders of the dopaminergic system.Diminished glucose transport in Alzheimer's disease: dynamic PET studies.Correlations of regional postmortem enzyme activities with premortem local glucose metabolic rates in Alzheimer's disease.Regional cerebral blood flow correlates of visuospatial tasks in Alzheimer's disease.Brain SPECT in dementia. A clinical-scintigraphic correlation.PET Scan Misses Cutaneous Melanoma Metastasis with Significant Tumour Size and Tumour Thickness.Cognitive reserve: a SPECT study of 132 Alzheimer's disease patients with an education range of 0-19 years.Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy.Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease.SPECT in dementia: clinical and pathological correlation.
P2860
Q26770766-026BAC6E-0B52-4DE2-996C-98CF008B4928Q27014791-1E80A3E2-3D4C-4E7D-B056-5E32A94FD714Q28346298-9FAA3BB2-A991-4035-8B60-D9BDD72DE8F3Q28484016-A3C5DA9A-8709-487C-BA37-B5ED320C74DFQ30436083-102CCF92-756E-4D6C-984B-CB6CDD4B6478Q30627959-FAC9BCD3-CB4C-4D14-A650-73518AFB6219Q33432903-E5B36EBF-1C68-4966-BB3B-3DD3BB66DD43Q34095846-759E22BC-E38A-4E98-818F-EE018719ADCAQ34518939-F1D79A27-6DB6-4610-B294-AE923143E78DQ34518966-A86B4AC3-50D6-4F59-9528-853E72293378Q34528053-2D6FD814-B0DB-43A7-8CBA-DBD5873723A7Q34775417-09CF42FD-3BBF-4548-8D64-DEE9E0D6B24DQ37510090-17697C49-E6FC-4559-9765-52D3D7E7E2B4Q39515095-213256CD-F388-4DE6-B5A1-014D24B985A0Q41096506-820C6664-7543-4F23-AF0D-E65D2EAB9FE0Q41441626-497F6C4F-7053-4D39-8569-F051218FAA4DQ41954486-1C5EDA35-F1DC-463D-B3F2-6A876A2C1E98Q42858013-BB8FC6D9-B7A9-4185-B351-F4117FE94E26Q43974906-FF3B8DFB-3E34-4433-85B1-893FD9848560Q47770932-63C88B72-4EF8-4D1F-B198-8BE29A5BD3E2Q48210325-C5BD533F-94DF-456E-8F5A-6B585E4BC8F7Q48226352-117A0E44-952E-4165-B912-36E59DC03E8EQ48468074-DAED4CCA-CF41-4AA7-BA5B-D53969B34817Q48565626-7C074796-D26F-4C55-939D-923D7C28132EQ48783668-9AECA398-D008-42D8-BE31-E6FAC187622AQ48853089-1212F82C-215A-4056-9F78-32FFA361D266Q48863172-E372BF06-8C48-47B1-A72C-5FACAD3E11EBQ48922245-0791284A-B8C0-40E1-A44D-7C85155F0E8CQ49837639-D86FB45B-5821-433D-9C6C-D01BC372720CQ51931108-A835FA2D-7509-420D-9D36-EAE8C863E0A0Q52062294-9558F2AB-AB35-410D-B7B5-789FBC8B7775Q52520990-F0EECDF0-F76E-4DB7-BE69-24EF9FD5BF0DQ53200614-DA80D329-B870-41FA-A26B-7889EB2F50EC
P2860
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
@en
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
@nl
type
label
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
@en
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
@nl
prefLabel
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
@en
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
@nl
P2093
P356
P1433
P1476
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
@en
P2093
P304
P356
10.1212/WNL.36.12.1569
P407
P577
1986-12-01T00:00:00Z